Urinary tract infections (UTIs), one of most common infections worldwide, face high recurrence rates and increasing antimicrobial resistance. Probiotic bacteria, especially of the genus Lactobacillus, are considered a promising preventive and/or treatment therapy against UTIs. In order to elucidate the mechanisms involved in these beneficial effects, we studied the impact of different Lactobacillus strains (Lactobacillus salivarius UCM572, L. plantarum CLC17 and L. acidophilus 01) in the adherence of reference and clinical uropathogenic strains (Escherichia coli ATCC R 53503, E. coli 10791, Enterococcus faecalis 04-1, En. faecalis 08-1 and Staphylococcus epidermidis 08-3) to T24 epithelial bladder cells. In general, the Lactobacillus strains with previous in vivo evidence of beneficial effects against UTIs (L. salivarius UCM572 and L. acidophilus 01) significantly inhibited the adherence of the five uropathogens to T24 cells, displaying percentages of inhibition ranging between 22.2% and 43.9%, and between 16.5% and 53.7%, respectively. On the other hand, L. plantarum CLC17, a strain with no expected effects on UTIs, showed almost negligible anti-adherence effects.Therefore, these in vitro results suggest that inhibition of the adherence of uropathogens to epithelial bladder cells may be one of the mechanisms involved in the potential beneficial effects of probiotics against UTIs in vivo.
INTRODUCTION
Urinary tract infections (UTIs) are the most common bacterial infections, affecting 150 million people each year worldwide and deriving in high health care costs (Stamm and Norrby 2001; Foxman 2014) . Approximately one in three young healthy women will develop an UTI during her life and 30% of them will suffer frequent recurrent episodes (Foxman 2014) . UTIs are categorized into two major infections: cystitis or bladder infection when affects the lower urinary tract and pyelonephritis or kidney infection when the upper urinary tract is affected. The most common cause of UTIs is uropathogenic Escherichia coli (UPEC) although other Gram-negative, such as Klebsiella pneumoniae, as well as some Gram-positive bacteria, including some staphylococcal and enterococcal species, seem to be also implicated in the etiopathogeny of these infections (Flores-Mireles et al. 2015) . In fact, it has been recently pointed out that polymicrobial infections involving Gram-positive bacteria may be more prevalent than previously appreciated, and may impact pathological outcomes in the urinary tract (Kline and Lewis 2016) .
The high recurrence rates and the increasing antimicrobial resistance of uropathogens are prompting new non-antibiotic prophylaxis and therapeutic alternatives (Beerepoot and Geerlings 2016; Matulay, Mlynarczyk and Cooper 2016) . Consumption of cranberry (Vaccinium macrocarpon) has been widely recommended for prophylaxis against UTIs, although there is some current controversy about its degree of efficacy (Wang et al. 2012) . Although the mechanisms behind these effects are still unravelled, cranberry-derived metabolites seem to operate in the phase of bacteria adherence to uroepithelial cells, preventing uropathogen colonization and UTI progression (González de Llano et al. 2015 , Uberos et al. 2015 . Probiotic bacteria are considered another promising therapy in UTI prevention and treatment (Reid et al. 2001; Czaja et al. 2007; Barrons and Tassone 2008; Stapleton et al. 2011; Al-Ghazzewi and Tester 2016) .
The homeostasis of the vaginal microbial ecosystem, formed mainly by lactobacilli, is important to protect vaginal mucosa against colonization of pathogens and their potential ascending into the urinary system. Moreover, incomplete cure and recurrence of genitourinary infections lead to a shift in the local microbiota from a predominance of lactobacilli to coliform uropathogens (Barrons and Tassone 2008) . Therefore, instillation of Lactobacillus in the vaginal cavity is presented as a potential therapy against UTIs in woman (Al-Ghazzewi and Tester 2016). Many human intervention studies have evaluated if the consumption of specific Lactobacillus strains can prevent or treat UTIs (Stapleton et al. 2011; Beerepoot et al. 2012; Grin et al. 2013) . Recently, in a pilot study, Montorsi et al. (2016) have proved the efficacy of the combined intake of Lactobacillus rhamnosus SGL06, cranberry and vitamin C for the prevention of recurrent UTIs. Globally, the results of clinical studies about the effect of probiotics against UTIs remain inconclusive as a result of small sample sizes and use of incorrect dosing strategies and, therefore, more randomized clinical trials should be conducted to make a stronger recommendation (Beerepoot et al. 2013; Schwenger, Tejani and Loewen 2015; Beerepoot and Geerlings 2016) .
At present, there is still a lack of knowledge about the specific mechanisms involved in these potential beneficial effects of probiotics against UTIs. Among other plausible mechanisms, several in vitro studies have proven the inhibition of the adherence of pathogenic bacteria (i.e., UPEC and others) to epithelial vaginal cells by different Lactobacillus strains (Osset et al. 2001; Zárate and Nader-Macias 2006; Ojala et al. 2014; Ortiz et al. 2014) . Recently, Polewski et al. (2016) have evaluated the impact of lactobacilli in combination with cranberry A-type proanthocyanidins on reducing the invasiveness of extra-intestinal pathogenic E. coli (ExPEC) to intestinal cells. However, as far as we are aware, no data have been reported about effects of lactobacilli on uropathogen adherence to bladder cells.
In this context, the effect of different Lactobacillus strains on the adherence of several uropathogenic strains of E. coli, Staphylococcus epidermidis and Enterococcus faecalis to human epithelial bladder cells has been investigated in this study. For each uropathogenic strain (E. coli ATCC 53503, E. coli 10791, En. faecalis 04-1, En. faecalis 08-1 and S. epidermidis 08-3), different assays were performed in order to evaluate the capability of the Lactobacillus strains (L. salivarius UCM572, L. plantarum CLC17 and L. acidophilus 01) to exclude (exclusion assay), to compete with (competition assay) or to displace (displacement assay) them from T24 epithelial bladder cells.
MATERIALS AND METHODS

Probiotic strains and growing conditions
Three probiotic Lactobacillus strains were included in this work: (1) Lactobacillus salivarius UCM572, a strain previously isolated from the vaginal exudate of a 38-year-old healthy woman (with no reported UTI episodes in the past) and with the ability to inhibit, both in vitro and in vivo, the growth of a wide spectrum of Gram-negative and Gram-positive uropathogenic bacteria (unpublished results); (2) L. plantarum CLC17, a strain previously isolated from milk but with negligible activity against uropathogenic bacteria and with almost no ability to adhere to gut epithelial cells or mucins (Martín et al. 2009 ) and, therefore, with not expected beneficial effect on UTIs; and (3) L. acidophilus 01, a strain isolated from a commercial supplement that claims benefits against UTIs. All strains were kept frozen at -70
• C in a sterilized mixture of culture medium (MRS broth; Pronadisa, Madrid, Spain) and glycerol (80:20, v/v) . Inocula of the three Lactobacillus strains (∼10 8 CFU mL -1 ) were prepared by growing overnight the contents of thawed cryovials in MRS broth at 30
Bacteria were harvested by centrifugation (10 000 g, 10 min, 4
and resuspended in Dulbecco's phosphate-buffered saline solution (DPBS, Lonza Walkersville, Inc., USA).
Uropathogenic strains and growing conditions
Two UPEC strains were used for the adherence studies: Escherichia coli ATCC 53503, a strain that expresses P fimbriae (Brinton and Fusco, 1988) , and E. coli 10791 DSM 10791, a strain that harbors the fimH, papGII/III, focG, sfaS and hlyA genes (Rafsanjany et al. 2013 
Cell cultures
T24 cells (ATCC HTB4) were used in this study since they are similar to primary human bladder epithelial cells (Hilbert et al. 2008) . T24 bladder cells were grown and maintained in McCoy's 5A medium (Sigma-Aldrich, St. Louis, MO, USA) supplemented with 10% (v/v) fetal bovine serum at 37 • C and antibiotics (100 IU/mL penicillin and 100 μg/mL streptomycin) in an atmosphere of 5% CO 2 /95% air at constant humidity as previously described (González de Llano et al. 2015) . Cells were seeded in 24-well tissue plates and grown for 24 h to enable cell attachment and to obtain a cell monolayer.
Bacteria adherence assay
First, DPBS bacteria suspensions in (∼10 8 CFU mL -1 ) were prepared from overnight cultures. Then, confluent T24 cell monolayers (5 × 10 5 cells/well) were washed with DPBS to eliminate antibiotic residues and overlaid with 0.5 mL of either a bacterial suspension or DPBS (as the control medium). After 1 h at 37
• C in a 5% CO 2 atmosphere, wells were gently washed with DPBS to remove unbound bacteria. Cells and adhered bacteria were then detached using a 0.05% trypsin-EDTA solution and sonicated in an ultrasonic sonication bath (three pulses, 10 s on, 3 s off) at 40 kHz to recover bacteria associated with cells. Bacterial counts (CFU mL -1 ) were carried on TSA plates for E. coli strains, Enterococcus Selective Agar plates (Laboratories Conda) for enterococci, Manitol Agar plates (Laboratories Conda) for staphylococci and MRS plates for lactobacilli, as previously described (González de Llano et al. 2015) . The adherence percentage (%) was calculated as the number of adhered bacteria (CFU mL -1 )
relative to the total number of bacteria added initially multiplied by 100.
Exclusion, competition and displacement assays
The procedures used for the different in vitro anti-adherence (exclusion, competition and displacement) assays of uropathogens by lactobacilli are schematically shown in Fig. 1 . For the exclusion assay, the Lactobacillus suspension (∼10 8 CFU mL -1 ) was first added to the cell monolayers and, after 1 h, non-bound bacteria were removed. Then, the uropathogen suspension (∼10 8 CFU mL -1 ) was added to the wells and the mixture was incubated for a further 1 h. After this time, T24 cells and adhered bacteria (uropathogens/lactobacilli) were detached and uropathogen counting was carried out as described above (Fig. 1 ). For the displacement assay, the same experimental protocol was carried out, but adding first the uropathogen suspension (∼10 8 CFU mL -1 ) and later, the Lactobacillus suspension ( Fig. 1 ).
To test the ability of the Lactobacillus strains to compete with the uropathogens for adherence to T24 cells, both potential competitors (Lactobacillus strain and uropathogenic strain; ∼10 8 CFU mL -1 , each) were simultaneously added to the cells followed by incubation for 1 h. Non-bound bacteria were removed and the bacterial counts were carried out as described above (Fig. 1) . The inhibition of the adherence of uropathogens was expressed as a percentage using the following formula: Inhibition (%) = 100 × (1−T1/T2), where T1 and T2 are the adherence percentage of uropathogens to T24 cells in the presence and absence of lactobacilli, respectively. All cell culture assays were performed in duplicate and three independent experiments were carried out.
Statistical analysis
A paired sample t-test was conducted to evaluate whether pathogen adherence (%) in presence of Lactobacillus was different (P 0.01) from pathogen adherence in his absence (control). Also, one-way analysis of variance post hoc comparison using the Tukey HSD test (P 0.01) was used for the comparison of the values of inhibition (%) among those Lactobacillus stains that significantly decreased the % of adherence in respect to the control. The IBM SPSS program (v.22) for Windows was used for data processing.
RESULTS
Adherence of the bacterial strains to bladder epithelial cells
Initially, the capacity of the two UPEC strains (Escherichia coli ATCC 53503 and E. coli DSM 10791) and the three Gram-positive uropathogenic strains (Enterococcus faecalis 04-1, En. faecalis 08-1 and Staphylococcus epidermidis 08-3) to adhere to T24 cells were tested (Table 1 ). Both UPEC strains showed similar percentages of adherence to bladder cells (∼9.0%-9.8%) while those displayed by the staphylococcal, enterococcal and lactobacilli strains were slightly higher (∼10.5%-12.9%) ( Table 1) . Lactobacillus acidophilus 01 was the strain that showed the highest adherence ability in this assay (∼13%) ( Table 1) .
Effects of Lactobacillus strains on the adherence of uropathogens to bladder epithelial cells
The effect of each of the three Lactobacillus strains on the adherence of the five uropathogenic strains to bladder epithelial cells is shown in Table 2 . For each type of assay and each uropathogenic strain, significant differences from the control (no lactobacilli added) were indicated for every Lactobacillus strain tested (Table 2 ). To better show the impact of these antiadherence effects by lactobacilli, Fig. 2 displays the percentages of inhibition (%) by the Lactobacillus strains for each uropathogen. Significant differences among Lactobacillus stains were checked for those lactobacilli that significantly decreased the % of adherence to bladder cells (Fig. 2) .
In the exclusion assay, T24 cells were pre-incubated with the Lactobacillus strain before being exposed to the uropathogenic strain (Fig. 1) . Therefore, this assay estimated the capacity of the lactobacilli to prevent UTIs (preventive action). The three Lactobacillus strains decreased the adherence of the five uropathogenic strains to T24 cells but, with respect to the controls, significant differences (P < 0.01) were only seen for L. salivarius UCM572 and L. acidophilus 01 towards all the uropathogens, with the exception of E. coli ATCC 53503 (P 0.015 and 0.022, respectively) ( Table 2 ). In contrast, L. plantarum CLC 17 only significantly decreased the adherence of En. faecalis 04-1 ( Table 2 ). The inhibition of uropathogens adhesion ranged between 22.2% and 37.8% and between 17.5% and 25.9% for L. salivarius UCM572 and L. acidophilus 01, respectively (Fig. 2) . Lactobacillus salivarius UCM572 led to significantly higher inhibition percentages than L. acidophilus 01 for E. coli DSM 10791, En. faecalis 04-1 and S. epidermidis 08-3, while both strains had similar results in relation to the adherence of En. faecalis 08-1 (Fig. 2) . Among uropathogens, En. faecalis 04-1 and S. epidermidis 08-3 strains were the most sensitive to the anti-adherence action of the Lactobacillus strains, especially to that exerted by L. salivarius UCM572 (36.3 and 37.8% of inhibition, respectively) (Fig. 2) . indicate statistically significant differences (P 0.01) among Lactobacillus strains that were found to significantly decrease the % of adherence (Table 2 ).
In the competition assay, T24 cells were incubated with both Lactobacillus and uropathogenic strains at the same time (Fig. 1) , which can be considered as an estimation of the capacity of the lactobacilli to avoid recurrent UTIs (prophylactic action). The adherence of the five uropathogenic strains to T24 cells decreased when the pathogen was in the presence of the lactobacilli but, in comparison with the controls, significant differences (P<0.01) were seen for L. salivarius UCM572 and L. acidophilus 01 against all the uropathogens, with the exceptions of the later strain against E. coli ATCC 53503 and E. coli DSM 10791 (P = 0.036 and 0.039, respectively) ( Table 2 ). In contrast, L. plantarum CLC 17 only significantly decreased the adherence of En. faecalis 08-1 ( Table 2 ). The inhibition of uropathogens adhesion ranged between 27.6% and 38.7% and between 16.5% and 49.6% for L. salivarius UCM572 and L. acidophilus 01, respectively (Fig. 2) . Lactobacillus salivarius UCM572 led to significantly higher inhibition percentages than L. acidophilus 01 for E. coli ATCC 53503, E. coli DSM 10791 and S. epidermidis 08-3. The results obtained by both strains were similar for En. faecalis 08-1 while, only for En. faecalis 04-1, L. acidophilus 01 led to better anti-adherence percentages than L. salivarius UCM572 (Fig. 2) . Globally, En. faecalis strains were most sensitive to the anti-adherence action of the Lactobacillus strains than the remaining uropathogenic strains tested in this work, specially to that exerted by L. acidophilus 01 against En. faecalis 04-1 and En. faecalis 08-1 (49.6% and 37.4% of inhibition, respectively) (Fig. 2) .
Finally, in the displacement assay, T24 cells were exposed to the uropathogenic strains before being incubated with the lactobacilli (Fig. 1) . Therefore, this assay is design to estimate the capacity of the lactobacilli to attenuate UTIs (treatment action). Both L. salivarius UCM572 and L. acidophilus 01 significantly (P < 0.01) reduced the adherence of the five uropathogenic strains to the T24 cells (Table 2) . Again, L. plantarum CLC 17 only significantly decreased the adherence of En. faecalis 08-1 ( Table 2 ). The inhibition of the adhesion of the different tested uropathogens ranged between 32.0% and 43.9% and between 29.8% and 53.7% for L. salivarius UCM572 and L. acidophilus 01, respectively (Fig. 2) . Lactobacillus acidophilus 01 led to a significantly higher inhibition than L. salivarius UCM572 for En. faecalis 04-1 while both strains had similar results in relation to the adherence of the rest of uropathogenic strains (Fig. 2) . Among uropathogens, the enterococcal strains were the most sensitive to the anti-adherence action of the Lactobacillus strains, especially to that exerted by L. acidophilus 01 towards En. faecalis 04-1 and En. faecalis 08-1 (53.7% and 50.3% of inhibition, respectively) (Fig. 2) .
DISCUSSION
UTI and recurrent UTI are extremely common health problems, with an often unpredictable history, and usually, cause a strong discomfort among affected people. Thus, management and prevention of this condition is of utmost significance. The increasing resistance of uropathogens to antibiotics has prompted to reconsider empirical treatment of UTIs using antibiotics and, in this context, identifying new and effective strategies are a high priority in this field (Foxman and Buxton 2013; Al-Ghazzewi and Tester 2016) . One promising alternative is the use of probiotics in to replace uropathogens and restore a physiological urinary tract microbiota (Hoesl and Altwein 2005; Reid and Bruce 2006; Pearce et al. 2014; Whiteside et al. 2015; Brubaker and Wolfe, 2016) .
Adherence of pathogens to uroepithelial cell receptors seems to be the main step in the pathogenesis of UTIs (Mulvey 2002; Mysorekar and Hultgren 2006) ; as a consequence, inhibition of uropathogens adherence to human bladder epithelial cells may be a key mechanism by which some probiotic strains may play a role in preventing or treating such condition.
In this work, the methodology used for measuring uropathogen adhesion has been previously optimized and successfully applied to the study of the anti-adherence capacity of several phenolic metabolites against UPEC (González de Llano et al. 2015; Mena et al. 2016) . In addition to classical UPEC strains, some UTI-related staphylococcal and enterococcal strains were also included in this study. Such Gram-positive bacteria are common inhabitants of the human urinary tract but, on the other hand, they can also be important uropathogens, particularly among elderly population, pregnant woman or people with any other risk factor for UTIs; however, they are often underrated as UTI etiological agents (Kline and Lewis 2016) .
As expected, the selected strains (Escherichia coli ATCC 53503, E. coli DSM 10791, Enterococcus faecalis 04-1, En. faecalis 08-1 and Staphylococcus epidermidis 08-3) showed relevant adherence values to T24 cells (Table 1 ). The adhesion values of both E. coli strains were in accordance with data reported previously for these microorganisms (Rafsanjany et al. 2013; González de Llano et al. 2015) . Adhesion levels of three Lactobacillus strains were also high, especially in the case of Lactobacillus acidophilus 01 (Table 1), which suggests a strong affinity to uroepithelial receptors (Lee et al. 2003) . The values reported in this study for adherence of the lactobacilli strains to T24 cells were similar to those described for adhesion of other probiotic strains to Caco-2 cells (Gueimonde et al. 2006; Bustos et al. 2012) .
Our results confirm that some lactobacilli strains can block the adhesion of uropathogens (exclusion assay), can compete with pathogens for specific cell receptors (competition assay) and/or can provoke detachment of the uropathogens (displacement assay) from epithelial bladder cells. This anti-adherence capacity of lactobacilli against uropathogens was strongly dependent on the Lactobacillus strain. As expected, the two Lactobacillus strains with in vivo evidence of beneficial effects against UTIs (L. salivarius UCM572 and L. acidophilus 01) significantly inhibit the adherence of the five uropathogens to T24 cells, whereas the strain with no relevant properties regarding UTIs (L. plantarum CLC17) showed a very small capacity to inhibit the adherence of uropathogens. Globally, our in vitro experiments reinforce the idea that inhibition of the adherence of uropathogens to epithelial bladder cells may be one of the key mechanisms involved in the potential beneficial effects of probiotics against UTIs in vivo.
The anti-adhesive capacity of the lactobacilli tested in this study was not only dependent on each lactobacilli strain but it was also influenced by the uropathogenic species and/or strains and the infection stage. Thus, L. salivarius UCM572 seemed to be more efficient than L. acidophilus 01 when there was no previous infection (exclusion assay) or there was an incipient recurrent infection (competition). However, in the assay resembling advanced infection (displacement assay), L. acidophilus 01 led to higher inhibition rates (Fig. 2) . In general, En. faecalis strains were most sensitive to the anti-adherence action of Lactobacillus strains than the others uropathogenic species tested (E. coli and S. epidermidis) but, again, this depended on the infection phase (Fig. 2) .
The fact that inhibition of uropathogens was strain specific is in agreement with previous studies on antagonism between lactobacilli and UTI-related pathogens. In vitro assessments of antimicrobial activity against uropathogens, probably the property most commonly used for selection of probiotic strains for this specific target, have shown that there is a high variability depending on the specific probiotic strain and on the specific uropathogen (Delley et al. 2015; Shim, Lee and Lee 2016) . In fact, the mechanisms of action by which probiotics can protect against UTIs remain largely unknown. One of the reasons for women to suffer from acute and recurrence UTIs is the ability of uropathogens to form dense biofilms that are recalcitrant to treatment. Lactobacillus reuteri RC-14 and L. rhamnosus GR-1 are two well-characterized strains with proven beneficial activity in UTIs, and both have shown ability to cause noticeable killing of uropathogens (including UPEC and uropathogenic En. faecalis strains) even when they form thick biofilms (Velraeds et al. 1996; McMillan et al. 2011) . However, since these two lactobacilli strains display quite different properties, their mechanisms of action may be rather different. It has been suggested that, as RC-14 is hydrophobic and GR-1 relatively hydrophilic (Reid et al. 1992) , their method of penetrating the biofilms is not likely based on surface structure, but may involve production of lactic acid, hydrogen peroxide, bacteriocins, biosurfactantlike substances or other compounds present in spent culture supernatants (Velraeds et al. 1996; Cadieux et al. 2009 ). In addition, some commercial L. johnsonii, L. rhamnosus and L. acidophilus strains have also shown inhibition of UPEC growth, a fact that was associated to the production of lactic acid, which acted both as permeabilizer of the outer membranes of Gram-negative bacteria and as a chelating agent (Delley et al. 2015) .
Adhesion to the urinary epithelial cells is a complex process involving complex interactions between the commensal microbiota, uropathogens, immnune cells and epithelial cells. Escherichia coli and Enterococcus spp. express distinctive adhesive pili on their surface to bind to an uroepithelial receptors and establish colonization (Spaulding and Hultgren, 2016) , which could also influence the action of lactobacilli. On the other hand, Staphylococcus spp. are well known for their ability to drive the formation of biofilms in epithelial and mucosal surfaces and, upon interactions with UPEC, may favor the adhesion and colonization by the later. In this frame, adhesion of potential probiotic strains to epithelial cells of the urinary tract may be critical for UTI-related applications since it may be a pre-requisite for interaction with uropathogens, either through co-aggregation or by entering in their biofilms. Such close contact seems relevant for the activity of antimicrobial/surfactant compounds produced by probiotic bacteria.
In addition, adhesion strongly favors a complementary mechanism of action: immunomodulation in the urinary tract (Amdekar et al. 2011) . Although epithelial cells of the urinary tract recognize pathogenic bacteria through pattern recognition receptors on their surface, such as Toll-like receptors, and generate an immune response through the activation of the NF-kappaB pathway, some uropathogenic bacteria can subvert these cellular responses. The immunological outcome of E. coli challenge of bladder cells was influenced by L. rhamnosus GR-1 through an enhancement of the activation of NF-kappaB and TNF release. This was able to modulate the activation of the NF-kappaB through increased levels of TLR4 on the bladder cells and altered subsequent release of cytokines from urothelial cells (Karlsson et al. 2012) . Therefore, the strain can facilitate pathogen recognition and infection clearance.
In relation to the probable administration of probiotic lactobacilli for the treatment of UTIs, studies on selected probiotics (Lactobacillus sp.) have demonstrated that orally ingested probiotics can be found in vaginal exudates and fecal samples (Reid et al. 2001; Reid 2017) . Subsequently, the presence of lactobacilli in the urethra, bladder or ureters may due to ascendance of fecal or vaginal Lactobacillus through the urinary tract. Moreover, Lactobacillus translocation from the intestinal mucosa to distal mucosal surfaces is a physiological process that may also explain, at least partly, colonization of the urogenital tract following oral administration of selected Lactobacillus strains (Rodríguez 2014 ).
CONCLUSION
This paper shows for the first time the in vitro anti-adhesive capacity of Lactobacillus strains against uropathogens in epithelial bladder cells, suggesting that this may be one of the mechanisms involved in the potential beneficial effects of probiotics against UTIs. This anti-adhesive capacity of lactobacilli is not strongly influenced by the Lactobacillus strain, but also by the uropathogen strain and the infection stage. This fact makes difficult the standardization of a single probiotic strain in UTI prevention and/or treatment. Overall, these results strengthen the promising use of probiotics as therapy for prevention, prophylaxis and treatment of UTIs. In vitro methodologies like the one used in this work are valuable in the screening of target-specific probiotic strains, and in the understanding of mechanisms involved in their beneficial effects.
